GENELUX Corp Earnings Per Share Disclosure
| Year ended December 31, | ||||||||
| 2025 | 2024 | |||||||
| (in thousands, except share amounts) | ||||||||
| Numerator: | $ | (32,145 | ) | $ | (29,869 | ) | ||
| Net loss | ||||||||
| Denominator: | ||||||||
| Weighted-average basic shares outstanding | ||||||||
| Effect of dilutive securities | ||||||||
| Weighted-average dilutive shares outstanding | ||||||||
| Basic and dilutive net loss per share | $ | ) | $ | ) | ||||
| Year Ended December 31, | ||||||||
| 2025 | 2024 | |||||||
| Stock options | 6,711,979 | 5,375,323 | ||||||
| Stock warrants | 7,930,785 | 7,897,975 | ||||||
| RSUs | 1,221,432 | 621,364 | ||||||
| 15,864,196 | 13,894,662 | |||||||
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.